Executive Director, Head of US Rare Endocrinology and Rare Tumors
Core
Provide senior medical leadership and full US Medical Affairs strategic ownership for Alexion's Rare Endocrinology and Rare Tumors portfolio, defining strategy across marketed products, pipeline assets, and lifecycle management.
Role type
Executive Director, Head of US Rare Endocrinology and Rare Tumors
Builds
US Medical Affairs strategy and tactical plans for rare disease therapeutic areas
Domain
Biopharmaceuticals, Rare Diseases, Endocrinology, Oncology
Required skills
Advanced scientific or clinical degree (M.D., PharmD, Ph.D.), 12+ years biopharmaceutical industry experience, 10+ years leading Medical Affairs teams, strategic planning, cross-functional partnership, evidence generation, team leadership, digital/AI adoption
Preferred skills
Product lifecycle management, launch readiness, indication expansion, early and late clinical development, real-world evidence, investigator-sponsored research, external expert engagement, rare disease portfolio leadership
Technologies
AI, digital innovation tools
Responsibilities
Define and implement portfolio-wide US Medical Affairs strategy, lead the design and execution of strategy and tactical plans, serve as senior US medical leader in governance forums, lead and develop a high-performing Medical Affairs team, define portfolio priorities and budget planning, partner with Commercial, Market Access, HEOR, and other functions, provide leadership for launch readiness and evidence generation, lead reviews of US Medical Affairs activities, ensure publication planning and medical communication, drive scientific exchange and advisory boards, collaborate on medical content localization, ensure compliant content review, drive adoption of AI and digital innovation, identify training needs and implement medical training programs
Seniority
Executive, strategic leadership